Yonsei University · Medicine
Professor Ho-Seong Kim's research lab focuses on the insulin-like growth factor binding protein (IGFBP) family, particularly their roles in regulating cell proliferation, apoptosis, and metabolic functions. The lab investigates both IGF-dependent and IGF-independent actions of IGFBPs, with a strong emphasis on IGFBP-3 and IGFBP-7 in cancer biology and metabolic regulation. Key research directions include the molecular mechanisms underlying IGFBP-mediated cell cycle arrest and caspase activation, as well as the physiological and pathological implications of IGFBP signaling in breast cancer and adipose tissue. The lab also explores the emerging concept of a low-affinity IGFBP superfamily, including novel ligands such as connective tissue growth factor (CTGF).
Figures are computed from collected data and may differ slightly.
The insulin-like growth factor (IGF) binding proteins (IGFBPs) modulate the actions of the insulin-like growth factors in endocrine, paracrine, and autocrine settings. Additionally, some IGFBPs appear to exhibit biological effects that are IGF independent. The six high-affinity IGFBPs that have been characterized to date exhibit 40-60% amino acid sequence identity overall, with the most conserved sequences in their NH2 and COOH termini. We have recently demonstrated that the product of the mac25
Insulin-like growth factor-binding protein (IGFBP)-3 has been shown to potently inhibit cell proliferation in various cell systems. However, the specific mechanisms involved in the antiproliferative action of IGFBP-3 have yet to be elucidated. In the present study, we demonstrate that IGFBP-3 induces apoptosis in an insulin-like growth factor (IGF)-independent manner through the activation of caspases involved in a death receptor-mediated pathway in MCF-7 human breast cancer cells. Induction of
Insulin-like growth factor binding protein (IGFBP)-3 has roles in modulating the effect of IGFs by binding to IGFs and inhibiting cell proliferation in an IGF-independent manner. Although recent studies have been reported that IGFBP-3 has also roles in metabolic regulation, their exact roles in adipose tissue are poorly understood. In this review, we summarized the studies about the biological roles in glucose and lipid metabolism. IGFBP-3 overexpression in transgenic mice suggested that IGFBP-3
The incidence of AEs of interest in rhGH-treated patients was low, and most of the neoplasms were benign and/or non-related to rhGH. Most patients benefited from the therapy in terms of height increment.
The insulin-like growth factor binding protein (IGFBP) family is a critical component of the insulin-like growth factor (IGF) system which regulate the biological actions of the IGFs and may also be capable of IGF-independent actions. To date, seven distinct IGFBPs have been described. Among these IGFBPs, IGFBPs-1-6 bind IGFs with high affinity, while only IGFBP-7 binds with low affinity. Recently, we have demonstrated that connective tissue growth factor (CTGF) also binds IGFs with low affinity
Insulin-like growth factor binding protein (IGFBP)-3 has been shown to potently inhibit proliferation of various cell types in an insulin-like growth factor (IGF)-independent manner. We have previously shown that IGFBP-3 induces apoptosis in an IGF-independent manner through the activation of caspases involved in a death receptor-mediated pathway in MCF-7 human breast cancer cells. In the present study, we present further evidence that IGFBP-3 inhibits cell proliferation through the induction of
Purpose: It has been reported that daily recombinant human growth hormone (GH) treatment showed beneficial effects on growth in prepubertal children with idiopathic short stature (ISS). The present study aimed to validate the GH (Eutropin ) effect on growth promotion and safety after short-term GH treatment. Materials and Methods: This study was an open-label, multicenter, interventional study conducted at nine university hospitals in Korea between 2008 and 2009. Thirty six prepubertal children
목 적 : 성조숙증은 여아에서 8세 미만, 남아에서 9세 미만에 2차 성징이 나타나는 경우로 정의하며, 진성 및 가성 성조숙증으로 구분한다. 성조숙증의 발생빈도는 최근 급격히 증가하고 있어 사회적 문제로 대두되고 있다. 본 연구에서는 성조숙증 증상을 주소로 내원한 환아 들을 대상으로 진단별 분포, 진단명에 따른 임상적 특징을 살펴보고자 하였다. 방 법 : 2003년 1월부터 2007년 6월까지 연세의료원, 상계백병원, 건국의대병원, 분당 차병원에 성조숙증 증상을 주소로 내원한 환아를 진성 성조숙증, 가성 성조숙증, 유방 조기발육증, 조기 사춘기로 분류하였고, 진성 성조숙증은 특발성 성조숙증과 중추신경성 성조숙증으로 분류하였다. 진단 당시의 증상, 가족력, 과거력, 성별, 신장, 체중, 역연령, 골연령, 체질량지수 등을 조사하였다. 기저 및 성선자극호르몬방출호르몬(GnRH) 자극 후 성호르몬, 황체화호르몬(LH), 난포자극호르몬(FSH) 농도를 측정하였다. 원인질환을 확인하기위해 진
Purpose: It has been reported that daily recombinant human growth hormone (GH) treatment showed beneficial effects on growth in prepubertal children with idiopathic short stature (ISS). The present study aimed to validate the GH (Eutropin ®) effect on growth promotion and safety after short-term GH treatment. Materials and Methods: This study was an open-label, multicenter, interventional study conducted at nine university hospitals in Korea between 2008 and 2009. Thirty six prepubertal children
A 35-year-old woman received open thyroidectomy for a thyroid nodule that was confirmed as papillary carcinoma. Whole-body 131I scintigraphy during thyroid ablation demonstrated high uptake in the thyroid bed and multiple focal hot spots in the thorax. SPECT/CT localized the hot spots to the right chest wall and axilla, as well as to the left chest wall. The surgeon recognized these sites to concur with the transaxillary tract used during endoscopic thyroidectomy for nodular hyperplasia 8 years
Open papers in the app to read, cite, and organize with AI.